https://lipidmatters-orginal.rouge-marketing.com/sglt2-inhibitors-in-patients-with-heart-failure-a-comprehensive-meta-analysis-of-five-randomised-controlled-trials/ 2024-02-22T08:45:55+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/02/SGLT2-inhibitors-in-patients-with-heart-failure-a-comprehensive-meta-analysis-of-five-randomised-controlled-trials.jpg https://lipidmatters-orginal.rouge-marketing.com/polypill-for-prevention-of-cardiovascular-diseases-with-focus-on-non-alcoholic-steatohepatitis-the-polyiran-liver-trial/ 2024-02-22T08:49:37+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/02/Polypill-for-prevention-of-cardiovascular-diseases-with-focus-on-non-alcoholic-steatohepatitis-the-PolyIran-Liver-trial.jpg https://lipidmatters-orginal.rouge-marketing.com/empagliflozin-in-the-treatment-of-heart-failure-with-reduced-ejection-fraction-in-addition-to-background-therapies/ 2024-02-22T09:08:01+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/02/Empagliflozin-in-the-treatment-of-heart-failure-with-reduced-ejection-fraction-in-addition-to-background-therapies-and-therapeutic-combinations-EMPEROR-Reduced.jpg https://lipidmatters-orginal.rouge-marketing.com/empagliflozin-and-serum-potassium-in-heart-failure-an-analysis-from-emperor-pooled/ 2024-02-22T09:12:18+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/02/Empagliflozin-and-serum-potassium-in-heart-failure_-an-analysis-from-EMPEROR-Pooled.jpg https://lipidmatters-orginal.rouge-marketing.com/effects-of-aspirin-on-dementia-and-cognitive-function-in-diabetic-patients-the-ascend-trial/ 2024-02-22T09:32:06+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/02/Effects-of-aspirin-on-dementia-and-cognitive-function-in-diabetic-patients-the-ASCEND-trial.jpg https://lipidmatters-orginal.rouge-marketing.com/dapagliflozin-in-heart-failure-with-mildly-reduced-or-preserved-ejection-fraction/ 2024-02-22T09:35:03+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/02/Dapagliflozin-in-Heart-Failure-with-Mildly-Reduced-or-Preserved-Ejection-Fraction.jpg https://lipidmatters-orginal.rouge-marketing.com/dapagliflozin-across-the-range-of-ejection-fraction-in-patients-with-heart-failure-a-patient-level-pooled-meta-analysis-of-dapa-hf-and-deliver/ 2024-02-22T09:38:26+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/02/Dapagliflozin-across-the-range-of-ejection-fraction-in-patients-with-heart-failure-a-patient-levelJ-pooled-meta-analysis-of-DAPA-HF-and-DELIVER.jpg https://lipidmatters-orginal.rouge-marketing.com/cardiovascular-and-renal-outcomes-with-efpeglenatide-in-type-2-diabetes/ 2024-02-22T09:49:04+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/02/Cardiovascular-and-Renal-Outcomes-with-Efpeglenatide-in-Type-2-Diabetes.jpg https://lipidmatters-orginal.rouge-marketing.com/bone-marrow-activation-in-response-to-metabolic-syndrome-and-early-atherosclerosis/ 2024-02-22T09:49:54+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/02/Bone-marrow-activation-in-response-to-metabolic-syndrome-and-early-atherosclerosis.jpg https://lipidmatters-orginal.rouge-marketing.com/bariatric-surgery-and-cardiovascular-disease-a-systematic-review-and-meta-analysis/ 2024-02-22T09:50:20+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/02/Bariatric-surgery-and-cardiovascular-disease-a-systematic-review-and-meta-analysis.webp https://lipidmatters-orginal.rouge-marketing.com/the-cardio-renal-metabolic-connection-a-review-of-the-evidence/ 2024-02-24T09:15:26+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/01/crm-featured-3.jpg https://lipidmatters-orginal.rouge-marketing.com/when-patients-with-heart-failure-are-on-sglt2-inhibition-water-conservation-takes-precedence-over-osmotic-diuresis/ 2024-05-25T07:58:38+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/When-patients-with-heart-failure-are-on-SGLT2-inhibition-water-conservation-takes-precedence-over-osmotic-diuresis-featured.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/When-patients-with-heart-failure-are-on-SGLT2-inhibition-water-conservation-takes-precedence-over-osmotic-diuresis.webp https://lipidmatters-orginal.rouge-marketing.com/the-global-burden-diseases-datathe-2023-almanac1990-2023-calls-for-compelling-urgency-for-global-action/ 2024-05-25T08:08:10+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/The-Global-Burden-Diseases-Data-2023-Almanac-calls-for-compelling-urgency-for-Global-Action-Featured.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/The-Global-Burden-Diseases-Data-2023-Almanac-calls-for-compelling-urgency-for-Global-Action.webp https://lipidmatters-orginal.rouge-marketing.com/administration-of-metformin-before-meals-may-optimize-its-effects-in-improving-post-prandial-glycemic-control/ 2024-05-25T08:19:26+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/Administration-of-metformin-before-meals-may-optimize-its-effects-in-improving-post-prandial-glycemic-control.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/Administration-of-metformin-before-meals-may-optimize-its-effects-in-improving-post-prandial-glycemic-control.webp https://lipidmatters-orginal.rouge-marketing.com/recommended-sodium-fluid-intake-for-hf-patients-by-esc-to-be-1-1-5l-day/ 2024-05-25T08:20:28+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/Recommended-Sodium-Fluid-Intake-for-HF-Patients-by-ESC-to-be-1-1.5L-per-day-featured.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/Recommended-Sodium-Fluid-Intake-for-HF-Patients-by-ESC-to-be-1-1.5L-per-day.webp https://lipidmatters-orginal.rouge-marketing.com/even-when-low-density-lipoprotein-cholesterol-levels-are-under-strict-control-elevated-lipoproteina-lpa-concentrations-are-linked-to-an-increased-risk-of-cardiovascular-events-however-there-i/ 2024-05-25T13:50:37+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/Lipoproteina-Blood-Levels-and-Cardiovascular-Risk-Reduction-With-Icosapent-Ethyl-featured.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/Lipoproteina-Blood-Levels-and-Cardiovascular-Risk-Reduction-With-Icosapent-Ethyl.webp https://lipidmatters-orginal.rouge-marketing.com/recommendations-for-treatment-of-hf-in-patients-with-hfref-and-diabetes/ 2024-05-26T08:15:28+00:00 https://lipidmatters-orginal.rouge-marketing.com/recommendation-for-diagnosing-diabetes/ 2024-06-09T12:23:23+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-1.png https://lipidmatters-orginal.rouge-marketing.com/score-2-diabetes-estimating-10-year-cardiovascular-risk/ 2024-06-09T12:34:11+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-5.png https://lipidmatters-orginal.rouge-marketing.com/cardiovascular-risk-categories-in-t2d/ 2024-06-09T12:35:51+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-3.png https://lipidmatters-orginal.rouge-marketing.com/recommendation-for-assessing-cardiovascular-risk-in-patient-with-t2d/ 2024-06-09T12:39:25+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-4.png https://lipidmatters-orginal.rouge-marketing.com/recommendations-for-reducing-weight-in-patient-with-t2d-with-or-without-cvd/ 2024-06-09T12:41:23+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-6.png https://lipidmatters-orginal.rouge-marketing.com/esc-guidelines-for-treatment-of-hf-patients-with-diabetes/ 2024-06-09T12:54:20+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-7.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-8.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-9.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-10.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-11.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-12.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-13.png https://lipidmatters-orginal.rouge-marketing.com/management-of-af-in-patients-with-diabetes/ 2024-06-09T12:56:57+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-14.png https://lipidmatters-orginal.rouge-marketing.com/management-of-cardiovascular-disease-in-patients-with-type-2-diabetes/ 2024-06-09T13:01:03+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image.jpeg https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-15.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-16.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-17.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-18.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-19.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-20.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-21.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-22.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-23.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-24.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-25.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-26.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-27.png https://lipidmatters-orginal.rouge-marketing.com/revised-concepts-2023-guidelines/ 2024-06-09T13:02:14+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-28.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-29.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-30.png https://lipidmatters-orginal.rouge-marketing.com/empagliflozin-reduces-liver-fat-in-individual-with-or-without-diabetes/ 2024-06-11T08:38:37+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/good-reads-portfolio.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/image.png https://lipidmatters-orginal.rouge-marketing.com/venturing-the-link-between-cardio-renal-metabolic-diseases/ 2024-06-11T08:39:14+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/good-reads-portfolio.webp https://lipidmatters-orginal.rouge-marketing.com/recommendations-for-reducing-weight-in-patient-with-t2d-with-or-without-cvd-2/ 2024-06-11T08:52:46+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-31.png https://lipidmatters-orginal.rouge-marketing.com/recommendation-of-physical-exercise-activity-in-patients-with-t2d-with-or-without-cvd/ 2024-06-11T08:54:13+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-32.png https://lipidmatters-orginal.rouge-marketing.com/recommendation-for-smoking-cessation-in-patients-with-t2d-with-or-without-cardiovascular-disease/ 2024-06-11T08:55:01+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-33.png https://lipidmatters-orginal.rouge-marketing.com/recommended-guide-to-glycaemic-targets-in-patients-with-t2d-and-cvd/ 2024-06-11T08:55:50+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-34.png https://lipidmatters-orginal.rouge-marketing.com/recommendation-for-glycaemic-targets-in-patients-with-diabetes/ 2024-06-11T08:56:33+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-35.png https://lipidmatters-orginal.rouge-marketing.com/glucose-lowering-treatment-for-patients-with-t2d-to-reduce-cvd-based-on-the-presence-of-atherosclerotic-cvd/ 2024-06-11T08:57:18+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-36.png https://lipidmatters-orginal.rouge-marketing.com/glucose-lowering-treatment-for-patient-with-t2d-and-atherosclerotic-cardiovascular-disease-to-reduce-cardiovascular-risk/ 2024-06-11T08:58:03+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-1.jpeg https://lipidmatters-orginal.rouge-marketing.com/recommendation-for-glucose-lowering-treatment-for-patients-with-t2d-and-atherosclerotic-cvd-to-reduce-cvd-risk/ 2024-06-11T08:58:45+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-37.png https://lipidmatters-orginal.rouge-marketing.com/hypertension-and-diabetes/ 2024-06-11T08:59:27+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-38.png https://lipidmatters-orginal.rouge-marketing.com/recommendation-for-blood-pressure-management-in-patients-with-diabetes/ 2024-06-11T09:00:20+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-39.png https://lipidmatters-orginal.rouge-marketing.com/recommendation-for-the-management-of-dyslipidaemia-in-patients-with-diabetes/ 2024-06-11T09:01:28+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-40.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-41.png https://lipidmatters-orginal.rouge-marketing.com/antithrombotic-therapy-and-diabetes/ 2024-06-11T13:36:34+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-42.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-43.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-44.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-45.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-46.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-47.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-48.png https://lipidmatters-orginal.rouge-marketing.com/recommendation-for-multifactorial-approach-to-risk-factors-management-in-diabetes/ 2024-06-11T13:40:39+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-49.png https://lipidmatters-orginal.rouge-marketing.com/recommendations-for-a-multifactorial-approach-in-patients-with-type-2-diabetes-with-and-without-cardiovascular-disease/ 2024-06-11T13:41:32+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-50.png https://lipidmatters-orginal.rouge-marketing.com/recommendation-for-revascularisation-in-patients-with-diabetes/ 2024-06-11T13:43:04+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/esc-logo.webp https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/06/image-51.png https://lipidmatters-orginal.rouge-marketing.com/crm-fun-quiz-2/ 2024-06-23T23:01:00+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/CRM-Quiz-1920x800-1.webp https://lipidmatters-orginal.rouge-marketing.com/crm-fun-quiz-2-2/ 2024-06-30T23:01:00+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/CRM-Quiz-1920x800-1.webp https://lipidmatters-orginal.rouge-marketing.com/crm-fun-quiz-4/ 2024-07-07T23:01:00+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/CRM-Quiz-1920x800-1.webp https://lipidmatters-orginal.rouge-marketing.com/crm-quiz/ 2024-06-23T14:05:03+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/CRM-Quiz-1920x800-1.webp https://lipidmatters-orginal.rouge-marketing.com/can-smartphones-identify-patients-with-heart-failure/ 2024-07-10T07:52:45+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/07/image-1.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/07/image-1.png https://lipidmatters-orginal.rouge-marketing.com/is-there-any-association-between-hdl-c-hdl-p-increased-overall-risk-of-heart-failure/ 2024-07-10T07:55:42+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/07/image-2.png https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/07/image-2.png https://lipidmatters-orginal.rouge-marketing.com/crm-fun-quiz-5/ 2024-07-15T09:49:32+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/CRM-Quiz-1920x800-1.webp https://lipidmatters-orginal.rouge-marketing.com/crm-fun-quiz-6/ 2024-07-22T10:06:57+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/CRM-Quiz-1920x800-1.webp https://lipidmatters-orginal.rouge-marketing.com/crm-fun-quiz-7/ 2024-07-29T10:11:35+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/CRM-Quiz-1920x800-1.webp https://lipidmatters-orginal.rouge-marketing.com/crm-fun-quiz-8/ 2024-08-05T10:16:40+00:00 https://lipidmatters-orginal.rouge-marketing.com/wp-content/uploads/2024/05/CRM-Quiz-1920x800-1.webp